US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Niagen Bioscience

6.19

-0.1200-1.90%

Post-market: 6.300.1100+1.78%19:34 EST

Volume:730.84K

Turnover:4.56M

Market Cap:494.70M

PE:26.35

High:6.34

Open:6.31

Low:6.17

Close:6.31

52wk High:14.69

52wk Low:5.25

Shares:79.92M

Float Shares:51.41M

Volume Ratio:0.81

T/O Rate:1.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2349

EPS(LYR):0.1126

ROE:38.90%

ROA:15.60%

PB:7.00

PE(LYR):54.97

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BRIEF-Niagen Bioscience Inc - Partners With Truemed To Expand HSA/FSA Access For Tru Niagen

Niagen Bioscience Inc - Partners With Truemed to Expand Hsa/FSA Access for Tru Niagen

THOMSON REUTERS

Niagen's ChromaDex Acquires Nicotinamide Riboside Patents From Queen's University Belfast

MT Newswires Live

Niagen Bioscience Acquires Core Nicotinamide Riboside Patent Portfolio

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NAGE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":6.19,"timestamp":1768597200000,"preClose":6.31,"halted":0,"volume":730843,"hourTrading":{"tag":"盘后","latestPrice":6.3,"preClose":6.19,"latestTime":"19:34 EST","volume":18045,"amount":111754.43,"timestamp":1768610050909,"change":0.11,"changeRate":0.017771,"amplitude":0},"delay":0,"changeRate":-0.019017432646592586,"floatShares":51414700,"shares":79919957,"eps":0.234893,"marketStatus":"Closed Martin Luther King, Jr. Day","change":-0.12,"latestTime":"01-16 16:00:00 EST","open":6.31,"high":6.335,"low":6.165,"amount":4556563.684377,"amplitude":0.026941,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.234893,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":6.31,"preHourTrading":{"tag":"盘前","latestPrice":6.34,"preClose":6.31,"latestTime":"09:22 EST","volume":84,"amount":530.370036,"timestamp":1768573347020,"change":0.03,"changeRate":0.004754,"amplitude":0.038035},"postHourTrading":{"tag":"盘后","latestPrice":6.3,"preClose":6.19,"latestTime":"19:34 EST","volume":18045,"amount":111754.43,"timestamp":1768610050909,"change":0.11,"changeRate":0.017771,"amplitude":0},"volumeRatio":0.8065371575193772,"impliedVol":1.2606,"impliedVolPercentile":0.881},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":51414700,"roa":"15.60%","roe":"38.90%","lyrEps":0.112605,"volumeRatio":0.8065371575193772,"shares":79919957,"dividePrice":0,"high":6.335,"amplitude":0.026941,"preClose":6.31,"low":6.165,"week52Low":5.25,"pbRate":"7.00","psRate":"3.97","week52High":14.69,"institutionHeld":0,"latestPrice":6.19,"eps":0.234893,"divideRate":0,"volume":730843,"delay":0,"ttmEps":0.234893,"open":6.31,"prevYearClose":6.36,"prevWeekClose":6.19,"prevMonthClose":6.36,"prevQuarterClose":6.36,"fiveDayClose":6.52,"twentyDayClose":6.29,"sixtyDayClose":7.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-05-07","symbol":"NAGE","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-03-04","symbol":"NAGE","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2024-10-31","symbol":"NAGE","fiscalQuarterEnding":"2024/09","expectedEps":0.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1748322000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-01-16","current":26.352424,"percent":0.009615,"low":24.502282,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"high":80.643552,"avg":47.75264,"sd":17.329236,"marketCap":505362467},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467}],"updateTime":1768845364888},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603247988","title":"BRIEF-Niagen Bioscience Inc - Partners With Truemed To Expand HSA/FSA Access For Tru Niagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2603247988","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603247988?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:37","pubTimestamp":1768484247,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Inc - Partners With Truemed To Expand HSA/FSA Access For Tru NiagenJan 15 (Reuters) - Niagen Bioscience Inc NAGE.O:NIAGEN BIOSCIENCE INC - PARTNERS WITH TRUEMED TO EXPAND HSA/F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0CK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2603988267","title":"Niagen Bioscience Inc - Partners With Truemed to Expand Hsa/FSA Access for Tru Niagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2603988267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603988267?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:36","pubTimestamp":1768484191,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0CK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2593313431","title":"Niagen's ChromaDex Acquires Nicotinamide Riboside Patents From Queen's University Belfast","url":"https://stock-news.laohu8.com/highlight/detail?id=2593313431","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593313431?lang=en_us&edition=fundamental","pubTime":"2025-12-23 00:42","pubTimestamp":1766421739,"startTime":"0","endTime":"0","summary":"Niagen Bioscience  said Monday its ChromaDex subsidiary has acquired from Queen's University Belfast the patent portfolio for nicotinamide riboside previously shared or licensed to ChromaDex.Under an assignment agreement, the university assigned to ChromaDex all of its right, title and interest in the patent rights in exchange for an upfront payment of about $1 million, annual payments of $500,000 and 35,000 British pounds  from 2026 through 2038, and one-time payments of $1.5 million and $2 million in 2035 and 2038 respectively, Niagen said in its filing with the US Securities and Exchange Commission.Niagen said the acquired portfolio consists of the core patents supporting the production, composition and commercial use of nicotinamide riboside.The assignment agreement, executed by ChromaDex and the university last week, terminated their 2015 licensing and joint ownership agreement, Niagen said.Shares of Niagen were up more than 7% in recent Monday trading.Price: 6.98, Change: +0.46, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"2593438853","title":"Niagen Bioscience Acquires Core Nicotinamide Riboside Patent Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2593438853","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593438853?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:32","pubTimestamp":1766410332,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc. has acquired a comprehensive portfolio of patents covering nicotinamide riboside  and its salt forms from Queen’s University Belfast. This transaction consolidates ownership of key intellectual property related to NR production, composition, and commercial use, making Niagen Bioscience the sole owner of these assets and further strengthening its leadership position in the NAD+ industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL3djM38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE"],"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NAGE\",params:#limit:6,delay:false,,,undefined,":[]}}